dihydrotetrabenazine has been researched along with n,n-diisopropyltryptamine in 1 studies
| Studies (dihydrotetrabenazine) | Trials (dihydrotetrabenazine) | Recent Studies (post-2010) (dihydrotetrabenazine) | Studies (n,n-diisopropyltryptamine) | Trials (n,n-diisopropyltryptamine) | Recent Studies (post-2010) (n,n-diisopropyltryptamine) |
|---|---|---|---|---|---|
| 234 | 4 | 60 | 5 | 0 | 3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, LL; Cozzi, NV; Daley, PF; Feih, JT; Gopalakrishnan, A; Ruoho, AE; Shulgin, AT | 1 |
1 other study(ies) available for dihydrotetrabenazine and n,n-diisopropyltryptamine
| Article | Year |
|---|---|
Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter.
Topics: Animals; Blood Platelets; Cell Line; Hallucinogens; Humans; N,N-Dimethyltryptamine; Paroxetine; Rats; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Spodoptera; Tetrabenazine; Tritium; Tryptamines; Vesicular Monoamine Transport Proteins | 2009 |